These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 6403533
1. A role for cyclooxygenase products in the formation of phosphatidic acid in stimulated human platelets. Differential mechanisms of action of thrombin and collagen. Siess W, Cuatrecasas P, Lapetina EG. J Biol Chem; 1983 Apr 25; 258(8):4683-6. PubMed ID: 6403533 [Abstract] [Full Text] [Related]
6. Platelet-activating factor stimulates the phosphatidylinositol cycle. Appearance of phosphatidic acid is associated with the release of serotonin in horse platelets. Lapetina EG. J Biol Chem; 1982 Jul 10; 257(13):7314-7. PubMed ID: 7045103 [Abstract] [Full Text] [Related]
7. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets. de Chaffoy de Courcelles D, De Clerck F. Eur J Pharmacol; 1990 Mar 13; 188(2-3):161-9. PubMed ID: 2318257 [Abstract] [Full Text] [Related]
8. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid. Brammer JP, Maguire MH. Br J Pharmacol; 1984 May 13; 82(1):61-72. PubMed ID: 6428500 [Abstract] [Full Text] [Related]
9. Stimulation of phosphatidic acid production in platelets precedes the formation of arachidonate and parallels the release of serotonin. Lapetina EG, Cuatrecasas P. Biochim Biophys Acta; 1979 May 25; 573(2):394-402. PubMed ID: 375988 [Abstract] [Full Text] [Related]
10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H, Stegmeier K. Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261 [Abstract] [Full Text] [Related]
12. Shape change induced in human platelets by platelet-activating factor. Correlation with the formation of phosphatidic acid and phosphorylation of a 40,000-dalton protein. Lapetina EG, Siegel FL. J Biol Chem; 1983 Jun 25; 258(12):7241-4. PubMed ID: 6345519 [Abstract] [Full Text] [Related]
13. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation. Gerrard JM, Robinson P, Narvey M, McNicol A. Biochem Cell Biol; 1993 Jun 25; 71(9-10):432-9. PubMed ID: 8192895 [Abstract] [Full Text] [Related]
14. Lysophosphatidic acid potentiates the thrombin-induced production of arachidonate metabolites in platelets. Lapetina EG, Billah MM, Cuatrecasas P. J Biol Chem; 1981 Dec 10; 256(23):11984-7. PubMed ID: 6795196 [Abstract] [Full Text] [Related]
16. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets. Lewis GP, Watts IS. Br J Pharmacol; 1982 Apr 10; 75(4):623-31. PubMed ID: 6802211 [Abstract] [Full Text] [Related]
17. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin. Connolly TM, Limbird LE. Proc Natl Acad Sci U S A; 1983 Sep 10; 80(17):5320-4. PubMed ID: 6577431 [Abstract] [Full Text] [Related]
18. Thrombin pretreatment of human platelets impairs thromboxane A2 synthesis from endogenous precursors in the presence of normal cyclooxygenase activity. Reimers HJ, Scharf RE, Baker RK. Blood; 1984 Apr 10; 63(4):858-65. PubMed ID: 6231068 [Abstract] [Full Text] [Related]
19. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD, Kinlough-Rathbone RL, Mustard JF. J Lab Clin Med; 1986 Feb 10; 107(2):148-53. PubMed ID: 3080538 [Abstract] [Full Text] [Related]
20. Mobilization of arachidonic acid in collagen-stimulated human platelets. Vedelago HR, Mahadevappa VG. Biochem J; 1988 Dec 15; 256(3):981-7. PubMed ID: 3146982 [Abstract] [Full Text] [Related] Page: [Next] [New Search]